• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究用药品管理中的审核经验与临床试验中的错误

Audit experiences in investigational medicinal product management and errors in clinical trials.

作者信息

Kim Yunjeong, Lee Heeyoung

机构信息

Center for Advanced Clinical Trial Education, Inje University, Gimhae, Gyeongnam, Republic of Korea.

Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae, Gyeongnam, Republic of Korea.

出版信息

Trials. 2025 Mar 21;26(1):100. doi: 10.1186/s13063-025-08795-w.

DOI:10.1186/s13063-025-08795-w
PMID:40119366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11927233/
Abstract

BACKGROUND

Clinical audits are essential to ensure that clinical research processes align with regulatory standards and best practices. Despite this, there has been no error assessment of the relationship between the errors in investigational medicinal product (IMP) management and clinical trial workers with audit experience.

METHODS

This study surveyed stakeholders with experience being audited to evaluate errors in IMP management and accountability during clinical trials through online survey system. The survey focused on errors in IMP export, dosing, storage, shipping, and labeling. Errors related to IMP management or accountability were evaluated with 22 specific criteria. Analysis included descriptive statistics and Pearson's correlation.

RESULTS

A total of 41 participants experiencing audits in clinical trial were enrolled in the current survey. The survey results revealed that the most frequent errors occurred in missing essential documents for shipment during IMP shipping and errors in label information, each accounting for 24 cases (58%). Additionally, a significant correlation was found between participants' age, work experience, and audit experience (coefficient = 0.77, p value < 0.05).

CONCLUSION

A survey of individuals with auditing experience identified common errors in IMP management, particularly missing shipment documents and incorrect labeling. To address these issues, clinical trial systems should implement regular error monitoring, standardized procedures, and comprehensive staff training to ensure safer and more efficient trials.

摘要

背景

临床审计对于确保临床研究过程符合监管标准和最佳实践至关重要。尽管如此,对于研究用药品(IMP)管理中的错误与具有审计经验的临床试验工作人员之间的关系,尚未进行错误评估。

方法

本研究通过在线调查系统对有被审计经验的利益相关者进行了调查,以评估临床试验期间IMP管理和责任方面的错误。该调查聚焦于IMP出口、给药、储存、运输和标签方面的错误。使用22条具体标准对与IMP管理或责任相关的错误进行评估。分析包括描述性统计和Pearson相关性分析。

结果

共有41名经历过临床试验审计的参与者参与了本次调查。调查结果显示,最常见的错误发生在IMP运输过程中缺少装运必需文件以及标签信息错误,各占24例(58%)。此外,参与者的年龄、工作经验和审计经验之间存在显著相关性(系数 = 0.77,p值 < 0.05)。

结论

对具有审计经验的人员进行的一项调查确定了IMP管理中的常见错误,尤其是缺少装运文件和标签错误。为解决这些问题,临床试验系统应实施定期错误监测、标准化程序和全面的员工培训,以确保试验更安全、更高效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0826/11927233/bc162c99b99f/13063_2025_8795_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0826/11927233/bc162c99b99f/13063_2025_8795_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0826/11927233/bc162c99b99f/13063_2025_8795_Fig1_HTML.jpg

相似文献

1
Audit experiences in investigational medicinal product management and errors in clinical trials.研究用药品管理中的审核经验与临床试验中的错误
Trials. 2025 Mar 21;26(1):100. doi: 10.1186/s13063-025-08795-w.
2
Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials.赞助商和研究人员对当前肿瘤学试验中研究性新药安全报告流程的看法。
Clin Trials. 2017 Jun;14(3):225-233. doi: 10.1177/1740774517700640. Epub 2017 Mar 26.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Direct-to-participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers.直接向临床试验参与者供应研究用药品在欧洲的实践:探索申办方、现场工作人员和快递员的经验。
Br J Clin Pharmacol. 2023 Dec;89(12):3512-3522. doi: 10.1111/bcp.15850. Epub 2023 Jul 29.
5
Need for User-Friendly Audit Tools: Investigating Dietitians' Use and Requirements of Clinical Documentation Audit Tools.对用户友好的审核工具的需求:调查营养师对临床文档审核工具的使用情况和需求。
J Hum Nutr Diet. 2025 Apr;38(2):e70058. doi: 10.1111/jhn.70058.
6
Planning an Academic Clinical Trial.规划一项学术性临床试验。
Methods Mol Biol. 2015;1317:287-313. doi: 10.1007/978-1-4939-2727-2_16.
7
Operation of a radiopharmacy for a clinical trial.临床试验用放射性药物药房的运作。
Semin Nucl Med. 2010 Sep;40(5):347-56. doi: 10.1053/j.semnuclmed.2010.06.002.
8
Assessing data quality and the variability of source data verification auditing methods in clinical research settings.评估临床研究环境中数据质量和源数据核查审核方法的可变性。
J Biomed Inform. 2018 Jul;83:25-32. doi: 10.1016/j.jbi.2018.05.010. Epub 2018 May 19.
9
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management.临床试验方案的风险评估:一种帮助医院药剂师减少实验药物管理中人为错误的工具。
Eur J Hosp Pharm. 2025 Feb 21;32(2):121-125. doi: 10.1136/ejhpharm-2024-004154.
10
[Audit of clinical trials in Argentina. Assessment of standardized operational procedures in 12 centers].[阿根廷的临床试验审计。对12个中心标准化操作程序的评估]
Medicina (B Aires). 1991;51(6):511-8.

本文引用的文献

1
Management of drug supply chain information based on "artificial intelligence + vendor managed inventory" in China: perspective based on a case study.基于“人工智能+供应商管理库存”的中国药品供应链信息管理:基于案例研究的视角
Front Pharmacol. 2024 Jul 16;15:1373642. doi: 10.3389/fphar.2024.1373642. eCollection 2024.
2
Predisposing Factors to Medication Errors by Nurses and Prevention Strategies: A Scoping Review of Recent Literature.护士用药错误的 predisposing 因素及预防策略:近期文献的范围综述 。(这里“predisposing”未准确对应中文词汇,可结合语境理解其含义)
Nurs Rep. 2024 Jun 26;14(3):1553-1569. doi: 10.3390/nursrep14030117.
3
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management.
临床试验方案的风险评估:一种帮助医院药剂师减少实验药物管理中人为错误的工具。
Eur J Hosp Pharm. 2025 Feb 21;32(2):121-125. doi: 10.1136/ejhpharm-2024-004154.
4
Paediatric medication incident reporting: a multicentre comparison study of medication errors identified at audit, detected by staff and reported to an incident system.儿科药物不良事件报告:在审核中发现的药物错误、工作人员发现的药物错误和向事件系统报告的药物错误的多中心比较研究。
BMJ Qual Saf. 2024 Sep 19;33(10):624-633. doi: 10.1136/bmjqs-2023-016711.
5
Prevalence of medication errors and its related factors in Iranian nurses: an updated systematic review and meta-analysis.伊朗护士用药错误的发生率及其相关因素:一项最新的系统评价和荟萃分析。
BMC Nurs. 2024 Mar 14;23(1):175. doi: 10.1186/s12912-024-01836-w.
6
Direct-to-participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers.直接向临床试验参与者供应研究用药品在欧洲的实践:探索申办方、现场工作人员和快递员的经验。
Br J Clin Pharmacol. 2023 Dec;89(12):3512-3522. doi: 10.1111/bcp.15850. Epub 2023 Jul 29.
7
The value of adherence information during clinical pharmaceutical trials.临床药物试验中依从性信息的价值。
Clin Trials. 2022 Jun;19(3):326-336. doi: 10.1177/17407745221084127. Epub 2022 May 5.
8
Prevalence of Medication Errors and the Associated Factors: A Prospective Observational Study Among Cancer Patients at Mbarara Regional Referral Hospital.用药错误的发生率及其相关因素:姆巴拉拉地区转诊医院癌症患者的前瞻性观察研究
Cancer Manag Res. 2021 May 10;13:3739-3748. doi: 10.2147/CMAR.S307001. eCollection 2021.
9
[Medication errors reporting in drug clinical trials: Role of the clinical research pharmacist?].[药物临床试验中的用药错误报告:临床研究药师的作用?]
Therapie. 2021 Nov-Dec;76(6):735-742. doi: 10.1016/j.therap.2021.02.002. Epub 2021 Feb 5.
10
Important factors for effective patient safety governance auditing: a questionnaire survey.有效患者安全管理审计的重要因素:问卷调查
BMC Health Serv Res. 2018 Oct 20;18(1):798. doi: 10.1186/s12913-018-3577-9.